METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation

Abstract Background Neuroblastoma (NBL) is the most common extra-cranial solid tumour in childhood, with prognosis ranging from spontaneous remission to high risk for rapid and fatal progression. Despite existing therapy approaches, the 5-year event-free survival (EFS) for patients with advanced NBL...

Full description

Bibliographic Details
Main Authors: Ying Huang, Jieyi Ma, Cuiyun Yang, Paijia Wei, Minghui Yang, Hui Han, Hua Dong Chen, Tianfang Yue, Shu Xiao, Xuanyu Chen, Zuoqing Li, Yanlai Tang, Jiesi Luo, Shuibin Lin, Libin Huang
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Biomarker Research
Subjects:
Online Access:https://doi.org/10.1186/s40364-022-00414-z
_version_ 1811211577030868992
author Ying Huang
Jieyi Ma
Cuiyun Yang
Paijia Wei
Minghui Yang
Hui Han
Hua Dong Chen
Tianfang Yue
Shu Xiao
Xuanyu Chen
Zuoqing Li
Yanlai Tang
Jiesi Luo
Shuibin Lin
Libin Huang
author_facet Ying Huang
Jieyi Ma
Cuiyun Yang
Paijia Wei
Minghui Yang
Hui Han
Hua Dong Chen
Tianfang Yue
Shu Xiao
Xuanyu Chen
Zuoqing Li
Yanlai Tang
Jiesi Luo
Shuibin Lin
Libin Huang
author_sort Ying Huang
collection DOAJ
description Abstract Background Neuroblastoma (NBL) is the most common extra-cranial solid tumour in childhood, with prognosis ranging from spontaneous remission to high risk for rapid and fatal progression. Despite existing therapy approaches, the 5-year event-free survival (EFS) for patients with advanced NBL remains below 30%, emphasizing urgent necessary for novel therapeutic strategies. Studies have shown that epigenetic disorders play an essential role in the pathogenesis of NBL. However, the function and mechanism of N7-methylguanosine (m7G) methyltransferase in NBL remains unknown. Methods The expression levels of m7G tRNA methyltransferase Methyltransferase-like 1 (METTL1) were analyzed by querying the Gene Expression Omnibus (GEO) database and further confirmed by immunohistochemistry (IHC) assay. Kaplan-Meier, univariate and multivariate cox hazard analysis were performed to reveal the prognostic role of METTL1. Cell function assays were performed to evaluate how METTL1 works in proliferation, apoptosis and migration in cell lines and xenograft mouse models. The role of METTL1 on mRNA translation activity of NBL cells was measured using puromycin intake assay and polysome profiling assay. The m7G modified tRNAs were identified by tRNA reduction and cleavage sequencing (TRAC-seq). Ribosome nascent-chain complex-bound mRNA sequencing (RNC-seq) was utilized to identify the variation of gene translation efficiency (TE). Analyzed the codon frequency decoded by m7G tRNA to clarify the translation regulation and mechanism of m7G modification in NBL. Results This study found that METTL1 were significantly up-regulated in advanced NBL, which acted as an independent risk factor and predicted poor prognosis. Further in NBL cell lines and BALB/c-nu female mice, we found METTL1 played a crucial role in promoting NBL progression. Furthermore, m7G profiling and translation analysis revealed downregulation of METTL1 would inhibit puromycin intake efficiency of NBL cells, indicating that METTL1 did count crucially in regulation of NBL cell translation. With all tRNAs with m7G modification identified in NBL cells, knockdown of METTL1 would significantly reduce the levels of both m7G modification and m7G tRNAs expressions. Result of RNC-seq shew there were 339 overlapped genes with impaired translation in NBL cells upon METTL1 knockdown. Further analysis revealed these genes contained higher frequency of codons decoded by m7G-modified tRNAs and were enriched in oncogenic pathways. Conclusion This study revealed the critical role and mechanism of METTL1-mediated tRNA m7G modification in regulating NBL progression, providing new insights for developing therapeutic approaches for NBL patients.
first_indexed 2024-04-12T05:15:06Z
format Article
id doaj.art-a9a8275a837b457d891440d2529e03f8
institution Directory Open Access Journal
issn 2050-7771
language English
last_indexed 2024-04-12T05:15:06Z
publishDate 2022-09-01
publisher BMC
record_format Article
series Biomarker Research
spelling doaj.art-a9a8275a837b457d891440d2529e03f82022-12-22T03:46:39ZengBMCBiomarker Research2050-77712022-09-0110111410.1186/s40364-022-00414-zMETTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translationYing Huang0Jieyi Ma1Cuiyun Yang2Paijia Wei3Minghui Yang4Hui Han5Hua Dong Chen6Tianfang Yue7Shu Xiao8Xuanyu Chen9Zuoqing Li10Yanlai Tang11Jiesi Luo12Shuibin Lin13Libin Huang14Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen UniversityCenter for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Pediatrics, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Clinical Laboratory, The Second Affiliated Hospital of Guangzhou University of Chinese MedicineDepartment of Pediatrics, The First Affiliated Hospital, Sun Yat-sen UniversityCenter for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Pediatric Surgery, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Pediatrics, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Pediatrics, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Pediatrics, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Pediatric Surgery, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Pediatrics, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Pediatrics, The First Affiliated Hospital, Sun Yat-sen UniversityCenter for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen UniversityDepartment of Pediatrics, The First Affiliated Hospital, Sun Yat-sen UniversityAbstract Background Neuroblastoma (NBL) is the most common extra-cranial solid tumour in childhood, with prognosis ranging from spontaneous remission to high risk for rapid and fatal progression. Despite existing therapy approaches, the 5-year event-free survival (EFS) for patients with advanced NBL remains below 30%, emphasizing urgent necessary for novel therapeutic strategies. Studies have shown that epigenetic disorders play an essential role in the pathogenesis of NBL. However, the function and mechanism of N7-methylguanosine (m7G) methyltransferase in NBL remains unknown. Methods The expression levels of m7G tRNA methyltransferase Methyltransferase-like 1 (METTL1) were analyzed by querying the Gene Expression Omnibus (GEO) database and further confirmed by immunohistochemistry (IHC) assay. Kaplan-Meier, univariate and multivariate cox hazard analysis were performed to reveal the prognostic role of METTL1. Cell function assays were performed to evaluate how METTL1 works in proliferation, apoptosis and migration in cell lines and xenograft mouse models. The role of METTL1 on mRNA translation activity of NBL cells was measured using puromycin intake assay and polysome profiling assay. The m7G modified tRNAs were identified by tRNA reduction and cleavage sequencing (TRAC-seq). Ribosome nascent-chain complex-bound mRNA sequencing (RNC-seq) was utilized to identify the variation of gene translation efficiency (TE). Analyzed the codon frequency decoded by m7G tRNA to clarify the translation regulation and mechanism of m7G modification in NBL. Results This study found that METTL1 were significantly up-regulated in advanced NBL, which acted as an independent risk factor and predicted poor prognosis. Further in NBL cell lines and BALB/c-nu female mice, we found METTL1 played a crucial role in promoting NBL progression. Furthermore, m7G profiling and translation analysis revealed downregulation of METTL1 would inhibit puromycin intake efficiency of NBL cells, indicating that METTL1 did count crucially in regulation of NBL cell translation. With all tRNAs with m7G modification identified in NBL cells, knockdown of METTL1 would significantly reduce the levels of both m7G modification and m7G tRNAs expressions. Result of RNC-seq shew there were 339 overlapped genes with impaired translation in NBL cells upon METTL1 knockdown. Further analysis revealed these genes contained higher frequency of codons decoded by m7G-modified tRNAs and were enriched in oncogenic pathways. Conclusion This study revealed the critical role and mechanism of METTL1-mediated tRNA m7G modification in regulating NBL progression, providing new insights for developing therapeutic approaches for NBL patients.https://doi.org/10.1186/s40364-022-00414-zNeuroblastomaN7-methylguanosineEpigenetics
spellingShingle Ying Huang
Jieyi Ma
Cuiyun Yang
Paijia Wei
Minghui Yang
Hui Han
Hua Dong Chen
Tianfang Yue
Shu Xiao
Xuanyu Chen
Zuoqing Li
Yanlai Tang
Jiesi Luo
Shuibin Lin
Libin Huang
METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation
Biomarker Research
Neuroblastoma
N7-methylguanosine
Epigenetics
title METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation
title_full METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation
title_fullStr METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation
title_full_unstemmed METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation
title_short METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation
title_sort mettl1 promotes neuroblastoma development through m7g trna modification and selective oncogenic gene translation
topic Neuroblastoma
N7-methylguanosine
Epigenetics
url https://doi.org/10.1186/s40364-022-00414-z
work_keys_str_mv AT yinghuang mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT jieyima mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT cuiyunyang mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT paijiawei mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT minghuiyang mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT huihan mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT huadongchen mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT tianfangyue mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT shuxiao mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT xuanyuchen mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT zuoqingli mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT yanlaitang mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT jiesiluo mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT shuibinlin mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation
AT libinhuang mettl1promotesneuroblastomadevelopmentthroughm7gtrnamodificationandselectiveoncogenicgenetranslation